| Date | Title | Description |
| 14.09.2026 | FDA Approves Telix's Brain Cancer Imaging Drug Pixclara | Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer).
Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from treatment-related change in adults and... |
| 14.09.2026 | Want to lower your risk of dementia? It doesn’t involve a blood test | Getting your Trinity Audio player ready...
By LAURAN NEERGAARD
WASHINGTON (AP) — New blood tests that might predict Alzheimer’s years before symptoms begin may sound tantalizing for people who worry about later-in-life dementia. But doctors... |
| 01.09.2026 | Years after he quit smoking, a lung cancer scan saved his life | Getting your Trinity Audio player ready...
By Paula Span, KFF Health News
Dennis Schmidt started smoking as a teenager, when that was so unexceptional that his Catholic high school designated outdoor “senior smoking quarters,” where student... |
| 31.08.2026 | Football is America’s game. Its players deserve better protection. (Editorial) | Getting your Trinity Audio player ready...
The time is upon us: the opening of another season of college football and the NFL, and like most of you we are excited for what’s to come.
Football is an incredible game, combining skill, speed, s... |
| 28.08.2026 | Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's | HONG KONG, Aug. 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2026 interim results. During the reporting period, the Company achieved record-high drug sales revenue, further adva... |
| 20.08.2026 | Network Bio Launches With $50 Million Financing And $30+ Million AI Partnership To Build Disease-Specific Models | Network Bio has launched with $50 million in financing to build disease-specific artificial intelligence models trained on large-scale human tissue, blood, molecular and clinical datasets, as the biotechnology company seeks to apply AI to d... |
| 20.08.2026 | Network Bio нашла $50 млн и потратит их на развитие ИИ-платформы для анализа биоданных | Американская биотехнологическая компания Network Bio привлекла $50 млн инвестиций для развития ИИ-платформы, которая объединяет данные о тканях пациентов, образцы крови, молекулярные показатели и долгосрочные клинические результаты.
Getty I... |
| 19.08.2026 | Network Bio Raises $50M in Funding | Network Bio, a Boston, MA-based biotechnology company building disease-specific AI models from human biological data, raised $50M in financing.
Backers included Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund, JSL He... |
| 19.08.2026 | Network Bio Raises $50M to Expand Disease-Specific AI Platform | Network Bio Raises $50M for AI Research
Network Bio has raised $50 million in financing to expand its biotechnology and artificial intelligence platform. The round includes Section 32, Thiel Bio, Founders Fund and Breyer Capital. Blue Ventu... |
| 19.08.2026 | Mass General Brigham Launches First Home Hospital Trials for Dementia and Behavioral Health | What You Should Know
Mass General Brigham announced the launch of two clinical trials to evaluate acute, hospital-level care delivered in the home for patients living with dementia and those experiencing primary psychiatric conditions.
The ... |
| 13.08.2026 | Brain Plasticity Switch Found: Gene Therapy Reverses Autism and Seizures in Adults | By Otis D. Sheehan
Published: Aug 13 2026, 10:48 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 11.08.2026 | HHT Patients Get First Phase 3 Drug Trial After 130 Years Without Treatment | By Donald C. Case
Published: Aug 11 2026, 10:53 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 28.07.2026 | Trump administration demands hospitals share emergency room records | Getting your Trinity Audio player ready...
By Amanda Seitz, Maia Rosenfeld, and Darius Tahir, KFF Health News
A tiny federal agency tasked with protecting the public from injuries caused by lawn mowers and coffeemakers is demanding that som... |
| 22.07.2026 | Capability vs. Aspiration: The New Litmus Test for AI in Healthcare
What the Evidence Shows
What Operators Actually Need
Building for the Conditions That Matter Most
The Litmus Test | Arun Ahuja, SVP and General Manager of Healthcare and Corporate at Illumia (
Walk the floor of any healthcare conference today, and the energy around artificial intelligence is palpable. The potential of the technology is genuinely transfor... |
| 17.07.2026 | HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027 | 250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in the HEALEY ALS Platform Trial so far
Anticipated topline efficacy and safety results for NUZ-001 now... |
| 15.07.2026 | Study shows a blood test can help identify healthy people at high risk for Alzheimer’s disease | Getting your Trinity Audio player ready...
By LAURAN NEERGAARD, AP Medical Writer
WASHINGTON (AP) — A blood test may predict if apparently healthy older adults are likely to develop Alzheimer’s symptoms in the next five or 10 years, researc... |
| 14.07.2026 | Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer | HONG KONG, July 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to advance a Phase II... |
| 23.06.2026 | Portal Biotechnologies Secures $9 Million for Cell Engineering Expansion | Portal Biotechnologies landed $9 million. This funding round, led by NFX, will propel commercial scaling of its cell engineering and drug discovery platform. The company's proprietary mechanoporation technology efficiently delivers complex ... |
| 18.06.2026 | Portal Biotechnologies Raises $9 Million To Expand Cell Engineering Platform | Portal Biotechnologies announced the closing of an oversubscribed $9 million financing round. The round was led by NFX, with participation from existing investors including IA Ventures, Pear VC, Undeterred Ventures, IKJ Capital, and TechU V... |
| 16.06.2026 | Crescom Launches Global PoC of Pediatric Musculoskeletal AI with Mass General Brigham | Mass General Brigham Department of Radiology Begins Clinical Validation and Utility of Three MediAI Pediatric Solutions
BOSTON and SEOUL, South Korea, June 16, 2026 /PRNewswire/ -- Crescom (CEO Jae Joon Lee), a medical AI company specializi... |
| 24.05.2026 | Dandelion Health Secures $14 Million to Power AI-Driven Drug Development | Dandelion Health, a clinical intelligence innovator, successfully raised $14 million in Series A funding. This investment accelerates its AI platform, revolutionizing life sciences. The platform leverages over 8 petabytes of multimodal pati... |
| 11.05.2026 | Pediatrics group issues new guidance on recess for the first time in 13 years | Getting your Trinity Audio player ready...
By LAURA UNGAR, AP Medical Writer
Recess isn’t just a fun break for grade schoolers. It’s crucial to good health and good grades for kids of all ages.
That’s the message from a leading pediatrician... |
| 09.05.2026 | Dandelion Health: $14 Million Series A Raised To Scale Multimodal Clinical AI Platform For Life Sciences | Dandelion Health, the clinical intelligence platform for life sciences, has raised a $14 million Series A funding round led by Healthier Capital, with participation from Colle Capital and existing investors Primary Venture Partners, Moxxie ... |
| 07.05.2026 | Houston humanoid robotics startup taps Amazon veteran to lead manufacturing | Persona AI, a Houston-based startup that’s developing AI-powered humanoid robots for manufacturers and other businesses, has hired Brian Davis as head of global manufacturing.
Davis previously guided teams at Amazon Robotics and Dell Techno... |
| 06.05.2026 | Houston startup’s brain implant for depression advances to clinical trial | Houston-based Motif Neurotech has received FDA approval to move forward with its first clinical trial for its innovative way to fight treatment-resistant depression and other mental health disorders.
The company has developed a brain-comput... |
| 30.04.2026 | Axoft Raises $55 Million Series A To Advance Clinical Trials For Its Bio-Inspired Brain-Computer Interface | Axoft, a neurotechnology company building implantable Brain-Computer Interfaces, has raised an oversubscribed $55 million Series A to expand its clinical trials globally and progress U.S. regulatory approval of its iBCI platform, bringing i... |
| 21.04.2026 | Alzheimer’s research: Boston scientists find blood test can predict disease before symptoms | Getting your Trinity Audio player ready...
The secret might be hidden in our blood.
Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. Rela... |
| 07.04.2026 | How MassMutual and Mass General Brigham turned AI pilot sprawl into production results | Enterprise AI programs rarely fail because of bad ideas. More often, they get stuck in ungoverned pilot mode and never reach production. At a recent VentureBeat event, technology leaders from MassMutual and Mass General Brigham explained ho... |
| 05.04.2026 | Digital Trends
Doctors came up with an app to save you from jumping to wrong conclusions | We have all been there. A delayed text reply suddenly means something is wrong. A neutral comment feels oddly critical. A small situation spirals into a full-blown worst-case scenario in seconds. That mental shortcut, where the brain jumps ... |
| 01.04.2026 | JAMA Study: AI Scribes Deliver Modest EHR Time Savings Across 5 Major Health Systems | Image Credit: DC Studio What You Should Know
The Scale of the Study: In the first major multi-site, multi-vendor study of its kind published in JAMA, researchers analyzed data from 8,581 ambulatory clinicians (including 1,809 AI scribe adop... |
| 27.03.2026 | Navinci to attend NextGen Omics and Spatial Biology US as silver sponsor and pre-launch new multiplex kit | Navinci to attend NextGen Omics and Spatial Biology US as silver sponsor and pre-launch new multiplex kit
Fri, Mar 27, 2026 12:51 CET Report this content
Uppsala, Sweden – March 27, 2026 – Navinci announced today its attendance at the Oxfor... |
| 23.03.2026 | Oryon Cell Therapies: $42 Million Raised For Autologous Neuron Replacement Therapies Targeting Parkinson’s Disease | Oryon Cell Therapies, a clinical-stage biotechnology company developing autologous neuron replacement therapies for Parkinson’s disease and other neurodegenerative disorders, announced it has emerged from stealth with total funding of $42 m... |
| 10.03.2026 | C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology | C-Further, an international consortium committed to creating new therapeutics for childhood cancers, today unveils the first early-stage therapeutic programmes for its pipeline, dedicated to paediatric oncology indications. Through its coll... |
| 09.03.2026 | InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare Practice | InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the appointment of Tim Ferris, M.D., as Vice President, Healthcare Practice. The announcement comes as healthcare lead... |
| 27.02.2026 | Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial | Highlights:
First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 for the treatment of ALS
Approximately 160 participants with ALS will be enrolled in a 36-week randomised, double... |
| 16.02.2026 | Кофеин в кофе и чае снижает риски развития деменции | Проанализировав данные более 131 000 человек, за которыми наблюдали более 40 лет, исследователи подтвердили, что ежедневное употребление кофе и чая однозначно защищает от развития болезни Альцгеймера и других форм когнитивных нарушений.Поче... |
| 26.01.2026 | [Opinion] 2026: The Dawn of AI-Driven Drug Development | (Yicai) Jan. 23 -- The next big leap for artificial intelligence in healthcare is no longer in the lab, but in clinical trials -- where drug development succeeds or fails.
For years, the conversation around AI in healthcare has been dominat... |
| 18.01.2026 | Strategic Systems Architecture and AI Governance: The Technical Contributions of Sandeep Reddy Kaidhapuram | Share
Share
Share
Share
Email
The infrastructure governing data flow within federal agencies and global enterprises represents the vital backbone of public safety and economic stability. As digital transformation shifts toward the integrati... |
| 22.12.2025 | MedTrainer Adds Chief Client Role, Appoints Erika Gotlieb To Maximize Success Of Healthcare Workforce Compliance Teams | MedTrainer announces the appointment of Erika Gotlieb as the company's first Chief Client Officer.
LAS VEGAS, Dec. 22, 2025 /PRNewswire-PRWeb/ -- MedTrainer, the all-in-one healthcare workforce compliance platform, announces the appointment... |
| 16.12.2025 | Concentric scale-ups: Mid-tier hospitals make expansion bets as large rivals consolidate | - |
| 02.11.2025 | Genetic variant increases risk of heart muscle disease common in individuals of African ancestry | Dilated cardiomyopathy (DCM), a leading cause of heart failure, is twice as common in Black individuals as in white individuals. This excess risk is not fully explained by known risk factors such as high blood pressure or socioeconomic barr... |
| 02.11.2025 | Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy | The 2025 Richard N. Merkin Prize in Biomedical Technology was jointly awarded to Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain in a ceremony and symposium at the Broad Institute on September 30, 2025. The prize, created by ... |
| 24.10.2025 | How many steps do you need? Researchers found 4,000 steps led to benefits for older group | Are you constantly looking at your watch or phone to check your step count as you strive to hit 10,000 steps a day?
Well, a new Mass General Brigham study shows that only 4,000 steps one or two days a week can lead to health benefits for a ... |
| 15.10.2025 | Shutdown forces Medicare patients off popular telehealth and hospital-at-home programs | By Tim Henderson, Stateline.org
The federal government shutdown is forcing a reckoning for two remote health care programs because they automatically expired Oct. 1.
The telehealth and in-home hospital care programs were both temporary — bu... |
| 11.10.2025 | Kneu Health: $5.6 Million Secured For Scaling Neurology Care Platform | Kneu Health, a precision neurology platform specializing in Parkinson’s disease and dementia management, has announced the closing of a $5.6 million oversubscribed seed funding round. This funding was co-led by Oxford Science Enterprises an... |
| 08.09.2025 | Another New Hampshire man gets a pig kidney as transplant trials are poised to start | By LAURAN NEERGAARD
WASHINGTON (AP) — A self-described science nerd is the latest American to get an experimental pig kidney transplant, at a crucial point in the quest to prove if animals organs really might save human lives.
The 54-year-o... |
| 27.08.2025 | NUHS SPEARHEADS AI-POWERED BRAIN CARE PROGRAMME TO TACKLE UNDERDIAGNOSIS AND IMPROVE PREVENTION OF DEMENTIA | Novel initiative in Asia integrates predictive AI with personalised health coaching to empower early action and prevention
SINGAPORE, Aug. 27, 2025 /PRNewswire/ -- Dementia remains a hidden epidemic in Singapore, with slightly more than hal... |
| 23.08.2025 | Breast cancer therapy can raise uterine cancer risk through a unique mechanism | Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- to 7-fold increased risk of developing uterine cancer within 2-5 years of tamoxifen treatment compared to the gener... |
| 06.08.2025 | Grand Winners Announced in 2025 Stevie® Awards for Technology Excellence | Amazon and Lexi AI are named top winners of the year in the 2025 Stevie Awards for Technology Excellence
Amazon and Lexi AI named top winners of the year
FAIRFAX, Va., Aug. 6, 2025 /PRNewswire-PRWeb/ -- Amazon, including Amazon Web Services... |
| 18.07.2025 | What is chronic venous insufficiency, the condition Trump was diagnosed with? | After photographs emerged of United States President Donald Trump with swollen ankles, the White House on Thursday (Jul 17) said he has been diagnosed with chronic venous insufficiency.
White House spokeswoman Karoline Leavitt revealed Trum... |
| 17.07.2025 | Trump is checked for lower leg swelling, diagnosed with a common condition in older adults | Leavitt did not say when Trump first noticed the swelling in his lower legs. As part of the president’s routine medical care and out of an “abundance of caution,” she said he had a “comprehensive exam” that included vascular, lower extremit... |
| 23.06.2025 | Scientists Develop Alternative to Nova Classification with ‘Nuanced’ Approach to UPFs | 5 Mins Read Researchers have created a new scoring system to classify ultra-processed foods, describing it as a “nuanced” alternative to the existing Nova classification.
It has been over 15 years since Dr Carlos Monteiro spearheaded the de... |
| 02.06.2025 | Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health | CLAIRITY BREAST provides clinicians with a first-in-class, novel platform for identifying future risk of breast cancer
A milestone in equitable healthcare, with potentially life-saving insights from a screening mammogram alone
FDA grants De... |
| 22.05.2025 | Sweep's $22.5M Funding: A Leap into the Future of Business Systems | In the bustling heart of New York City, a quiet revolution is brewing. Sweep, a trailblazer in agentic workspace technology, has just secured $22.5 million in Series B funding. This investment, led by Insight Partners and joined by Bessemer... |
| 20.05.2025 | Sweep Raises $22.5M in Series B Funding | Sweep, a NYC-based agentic workspace company for business systems, raised $22.5M in Series B funding.
The round was led by Insight Partners with participation from Bessemer Venture Partners.
The company intends to use the funds to accelerat... |
| 20.05.2025 | Sweep: $22.5 Million Series B Raised For Agentic Workspace For Business Systems | Sweep, a leading agentic workspace for business systems, announced $22.5 million in Series B funding led by Insight Partners with participation from Bessemer Venture Partners.
Sweep’s agentic layer continuously monitors metadata across syst... |
| 19.05.2025 | Tensions Rise as U.S. and Iran Dance Around Nuclear Proposals | The world watches as the U.S. and Iran engage in a high-stakes game of chess. The pieces are set, but the moves remain unclear. Recently, former President Trump claimed that Iran has received a proposal from the U.S. regarding its nuclear p... |
| 19.05.2025 | Glioblastoma brain cancer research: Study provides glimmer of hope | The new study was sparked by insight from the field of cancer neuroscience, which showed the success of using gabapentin in mouse models.
Intrigued by this research, Bernstock and colleagues looked at the outcomes of 693 glioblastoma patien... |
| 18.05.2025 | Biden has been diagnosed with aggressive prostate cancer | However, when prostate cancers need hormones to grow, as in Biden’s case, they can be susceptible to treatment that deprives the tumors of hormones.
Outcomes have improved in recent decades and patients can expect to live with metastatic pr... |
| 11.05.2025 | Carta Healthcare: $18.25 Million Series B1 Funding Raised For Advancing Clinical Data Abstraction | Carta Healthcare, a provider of AI-based clinical data abstraction, announced it has secured $18.25 million in Series B1 financing. The funding was led by UPMC Enterprises, with participation from new strategic investors, including Memorial... |
| 10.05.2025 | Harvard-trained couples therapists married nearly 50 years: Never, ever do these 5 things if you want a happy, successful relationship | As couples therapists and associate professors of psychiatry at Harvard Medical School, we spend a lot of time thinking about the keys to a long, loving relationship.
We’ve also been married nearly 50 years, and you can’t stay together that... |
| 08.05.2025 | Carta Healthcare's $18.25 Million Boost: A Leap into AI-Driven Clinical Data Solutions | In the fast-paced world of healthcare, data is the new gold. Carta Healthcare, a San Francisco-based innovator, has struck a lucrative deal, securing $18.25 million in Series B1 funding. This investment, led by UPMC Enterprises, marks a sig... |
| 07.05.2025 | Carta Healthcare Secures $18.25 Million in Series B1 Funding to Accelerate AI-Powered Clinical Data Abstraction and Analytics | Carta Healthcare, a leading provider of AI-powered clinical data abstraction, today announced it has secured $18.25 million in Series B1 financing. This investment will accelerate the company’s growth as demand surges among health systems a... |
| 07.05.2025 | Carta Healthcare Raises $18.25M in Series B1 Funding | Carta Healthcare, a San Francisco, CA-based provider of AI-powered clinical data abstraction solutions, raised $18.25M in Series B1 funding.
The round was led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex He... |
| 10.04.2025 | Potential Alzheimer’s disease therapeutic target identified in brain immune cells | Since the 1990s, researchers have found several immune system molecules that act like “brakes” on immune responses, leading to a new class of cancer drugs. One of these “immune checkpoint” molecules, called Tim-3 has recently been linked to... |
| 09.04.2025 | SignalFire's $1 Billion Bet on AI: A New Era for Venture Capital | In the bustling heart of San Francisco, a venture capital firm is making waves. SignalFire has just raised a staggering $1 billion, bringing its total assets under management to $3 billion. This is not just a financial milestone; it’s a bol... |
| 07.04.2025 | SignalFire Closes On $1B To Invest In Applied AI | 3 Shares Email Facebook Twitter LinkedIn
Bay Area-based SignalFire, a data-driven venture firm, has raised $1 billion for its fifth and largest fund, which it will invest in applied AI companies.
We spoke with founder Chris Farmer on the fi... |
| 02.04.2025 | Artis BioSolutions Raises Funding; Acquires Landmark Bio | Artis BioSolutions, a San Diego, CA-based company which specializes in the development and production of genetic medicines, raised an undisclosed amount in funding.
The round was led by Oak HC/FT.
The company intends to use the funds to fur... |
| 10.03.2025 | The Butter Battle: Plant Oils vs. Dairy Fats in the Quest for Longevity | In the world of nutrition, butter has long been a staple. It’s creamy, rich, and often seen as a culinary delight. But a new study suggests that this beloved dairy product may come with a hefty price tag: our health. Researchers from presti... |
| 10.03.2025 | Study: Consuming Plant-Based Oils Instead of Butter Could Significantly Reduce Mortality | A new study that analyzed data from over 200,000 people followed for more than 30 years has concluded that consuming plant-based oils instead of butter may have significant beneficial health effects.
Investigators from Mass General Brigham,... |
| 19.02.2025 | Abcuro: $200 Million (Series C) Raised For Advancing Medicine In Development For Inclusion Body Myositis | Abcuro – a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells – announced the closing of a $200 million Series C financing led by New... |
| 13.02.2025 | Abcuro Raises $200M in Series C Financing | Abcuro, a Newton, MA-based clinical-stage biotechnology company, raised $200M in Series C funding.
The round was led by New Enterprise Associates (NEA) joined by Foresite Capital with participation from existing investors including RA Capit... |
| 12.02.2025 | Harrison.ai Secures $112 Million to Revolutionize Medical Diagnostics | In a significant leap for healthcare technology, Harrison.ai has raised $112 million in Series C funding. This Australian healthtech company is on a mission to transform medical diagnostics through artificial intelligence. The funding round... |
| 11.02.2025 | Harrison.ai: $112 Million (Series C) Raised For AI-Based Medical Diagnostic Support | Harrison.ai, a leading global healthtech company and developer of AI-based medical diagnostic support and workflow solutions, announced the accelerated expansion of its operations into the US, which is a move supported by $112 million of Se... |
| 03.02.2025 | Quibim: Imaging Biomarker Company Raises $50 Million (Series A) | Quibim, a leading health technology company pioneering imaging biomarkers for precision medicine, announced the closing of its $50 million Series A funding round. And the company has experienced remarkable growth in the number of patients a... |
| 29.01.2025 | The Interplay of Work and Mental Health: A Balancing Act | In the intricate dance of life, work often takes center stage. It’s the rhythm that structures our days. Yet, for many, this rhythm is disrupted by the dissonance of anxiety and depression. Recent research sheds light on this connection, re... |
| 29.01.2025 | Health | Long-COVID patients are frustrated that federal research hasn’t found new treatments | Estimates of prevalence range considerably, depending on how researchers define long COVID in a given study, but the Centers for Disease Control and Prevention puts it at 17 million adults.
Despite long COVID’s vast reach, the federal gover... |
| 28.01.2025 | Quibim, a startup using AI imaging to aid in disease detection, raises $50M
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provi... | A Spanish artificial intelligence startup called Quibim S.L. said today it has closed on a $50 million early-stage funding round to help accelerate the development of its foundational models for medical imaging.
Today’s Series A round was l... |
| 28.01.2025 | Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital Chooses a United Imaging Next Generation PET/CT to Revolutionize the Study of Systems Physiology | HOUSTON, Jan. 28, 2025 /PRNewswire/ -- As pioneers in biomedical imaging and neuroscience, the researchers at the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH), a founding member of the Mass Gen... |
| 22.01.2025 | Health | Keeping blood pressure under control is critical. There’s a new option for tough cases | And only a fraction of patients have their hypertension well-controlled, meaning there’s a need for novel strategies. The Food and Drug Administration approved that “renal denervation” option about a year ago, based on studies showing a mod... |
| 20.01.2025 | The Tug-of-War Over Healthcare: AI's Promise and Medicaid's Peril | In the realm of healthcare, two powerful forces are at play: the rise of artificial intelligence (AI) and the looming threat to Medicaid. Both are reshaping the landscape, but not without challenges. The promise of AI is enticing, yet it co... |
| 18.01.2025 | Health | Health care AI, intended to save money, turns out to require a lot of expensive humans | In essence: You need people, and more machines, to make sure the new tools don’t mess up.
“Everybody thinks that AI will help us with our access and capacity and improve care and so on,” said Nigam Shah, chief data scientist at Stanford Hea... |
| 13.01.2025 | Navigating the Rising Tide of Payment Fraud: A Business Survival Guide | In the digital age, payment fraud is a lurking shadow. It creeps into businesses, large and small, stealing trust and money. The statistics are staggering. Transaction fraud losses soared from $17.5 billion in 2020 to an estimated $50 billi... |
| 12.01.2025 | Prudentia Sciences: AI-Based Life Sciences Marketplace Company Raises $7 Million | Prudentia Sciences, an AI-based technology platform for life sciences, announced its public launch, supported by $7 million in funding. This funding round was led by GV, with participation from Iaso Ventures and Virtue.
The company aims to ... |
| 12.01.2025 | How to hit peak fitness after 40: You can't train like you did in your 20s but being strategic will help | Not long ago, 40 was considered over the hill in sports. But we are increasingly seeing athletes, like the skier Lindsey Vonn, 40, and the climber Chris Sharma, 43, staging midlife comebacks. Peak performance is still within reach for the r... |
| 11.01.2025 | Prudentia Sciences: A New Dawn in Life Sciences Dealmaking | In the bustling corridors of Cambridge, Massachusetts, a new player is making waves in the life sciences arena. Prudentia Sciences has emerged with a mission: to revolutionize how biopharma companies navigate the complex world of drug devel... |
| 09.01.2025 | Prudentia Sciences Launches with $7M in Funding to Transform the Life Sciences Marketplace for Dealmaking | CAMBRIDGE, Mass.–(BUSINESS WIRE)–January 9, 2025–
Prudentia Sciences, an AI-powered technology platform for life sciences announced today its public launch, supported by $7 million in funding. The funding round was led by GV, with participa... |
| 24.12.2024 | GE Healthcare и AWS представили первую 3D-модель AI для анализа МРТ всего тела | Компания GE Healthcare в сотрудничестве с Amazon Web Services совершила значительный прорыв в области медицинской визуализации, представив первую в отрасли модель искусственного интеллекта, способную анализировать 3D-изображения МРТ всего т... |
| 23.12.2024 | Learn how GE Healthcare used AWS to build a new AI model that interprets MRIs | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
MRI images are understandably complex and data-heavy.
Because of this, developers training large language models ... |
| 21.12.2024 | Registration Is Now Open for Women's Health and Menopause, a Continuing Medical Education Course Offered by Harvard Medical School and Mass General Brigham | Women's Health and Menopause brochure cover
Course Director: Deborah Gomez Kwolek, MD, FACP, FAMWA, MSCP and Course Co-Director: Mahmooda Qureshi, MD, MSCP Join keynote speakers Jan L. Shifren, MD, MSCP, Anna Cabeca, DO, FACOG, ABAARM, Heat... |
| 09.10.2024 | Rippl: Virtual Dementia Care Company Raises $23 Million (Series A) | Rippl, a leader in virtual dementia care, announced the closing of its Series A funding round. Tina Hoang-To (Kin Ventures Founding General Partner) led the $23 million round with participation from Rippl’s seed investors ARCH Venture Partn... |
| 03.10.2024 | Virtual dementia care platform Rippl scores $23M | Photo: Halfpoint Images/Getty Images
Rippl, a company focused on providing mental health solutions to seniors with dementia and other cognitive conditions, announced it closed a $23 million Series A funding round.
Tina Hoang-To, Kin Venture... |
| 02.10.2024 | Rippl Secures $23M to Expand its Virtual Dementia Care Platform | What You Should Know:
– Rippl, a provider of virtual dementia care raises $23M ina Series A funding round led by Tina Hoang-To, Founding General Partner at Kin Ventures, with participation from existing investors including ARCH Venture Part... |
| 16.09.2024 | Generative AI Shows Promise in Reducing Bias in Opioid Prescriptions | What You Should Know:
– A groundbreaking study from Mass General Brigham researchers has revealed that large language models (LLMs), like ChatGPT-4 and Google’s Gemini, exhibit no racial or gender bias when suggesting opioid treatment plans... |
| 12.09.2024 | Navigating the Healthcare Supply Chain: A Balancing Act of Efficiency and Care | The healthcare supply chain is a complex web, often fraught with challenges. As hospitals and healthcare organizations grapple with rising costs and the need for efficiency, innovative solutions are emerging. One such solution is symplr, a ... |
| 12.09.2024 | Health | High Adderall doses tied to increased psychosis, mania risk: study | People who are taking high doses of Adderall face an increased risk for developing psychosis or mania, according to a new Mass General Brigham study.
Subscribe to continue reading this article. Already subscribed? To login in, click here.
O... |
| 12.09.2024 | MNA Faulkner Hospital Nurses to Issue Strike Notice on September 16 if Mass General Brigham Fails to Reach Agreement Respecting Nurses and Protecting Patient Care | Faulkner nurses voted 99.7% to authorize a potential one-day strike because MGB refuses to properly value the excellent patient care Faulkner nurses provide under extremely challenging conditions
BOSTON, Sept. 12, 2024 /PRNewswire/ -- A one... |
| 10.09.2024 | symplr to Showcase Comprehensive Supply Chain Solution at AHRMM 2024 | symplr.com
Innovative integration and efficiency in healthcare supply chain management drive bottom-line impact
HOUSTON, Sept. 10, 2024 /PRNewswire-PRWeb/ -- symplr®, a leading provider of enterprise healthcare operations software, will spo... |
| 10.09.2024 | Brigham and Women's Hospital Nurses Vote to Ratify New Contract that Averted Potential Strike and Seeks to Improve Nurse Staffing and Patient Care Conditions | Brigham nurses negotiated a new MNA contract last month following a 99.4% strike authorization vote motivated by nurses calling on MGB to invest in nurses and improve patient safety
BOSTON, Sept. 10, 2024 /PRNewswire/ -- The 4,000 Brigham a... |
| 28.08.2024 | Navigating the Future of Healthcare: Green Security's New Leadership and Immune Health Essentials | In the ever-evolving landscape of healthcare, change is the only constant. Recently, Green Security LLC, a key player in healthcare compliance and access management, announced a significant shift in leadership. Mickey Meehan, a seasoned vet... |
